|
| |
 |
| BRILINTA 60 MG |
ברילינטה 60 מ"ג |
|
|
|
|
| לא |
בסל הבריאות?: |
|
|
| Brilinta, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event (see sections 4.2 and 5.1).Limitations of use: 90 mg twice daily during the first year after an ACS event followed by 60 mg twice daily for additional 2 years. |
התוויה מאושרת: |
|
| FILM COATED TABLETS |
דרך מתן:
|
|
| ASTRA ZENECA (ISRAEL) LTD |
בעל רישום: |
|
| 156-54-34752-00 |
מספר רישום:
|
|
|
|
|
|
|
 |
INFO ON THE WEB |
מידע ברשת |
|
|
|
|
|
